mmVira's oncolytic product MVR-T3011 IT Intratumoral Injection Receives FDA Fast Track Designation for HNSCC Treatment

AdAlta partners with Oktopi to integrate advanced artificial intelligence into its drug development workflows, optimizing investment and licensing decisions.

Evaxion will present new preclinical data at IHW 2026 for EVX-V1, a novel AI-designed cytomegalovirus vaccine candidate addressing critical unmet needs.

Contract research organization Allucent launches the IGNITE network, connecting sponsors with over 250 pre-qualified sites to accelerate clinical trials.

Foresee Pharmaceuticals' oral therapy mirivadelgat joins the Phase 2a SLEIPNIR clinical trial to evaluate ALDH2 activation for Parkinson's disease care.